Skip to results
Modify your search
NARROW
1-3 of 3
Authors: Ignacio Matos
Sort by
Journal Article
Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials
Lee X Li and others
The Oncologist, Volume 28, Issue 4, April 2023, Pages e205–e211, https://doi.org/10.1093/oncolo/oyad043
Published: 11 March 2023
Journal Article
The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE‐1407)
Enrique Grande and others
The Oncologist, Volume 25, Issue 9, September 2020, Pages 745–e1265, https://doi.org/10.1634/theoncologist.2020-0033
Published: 11 February 2020
Journal Article
Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study
Jaume Capdevila and others
The Oncologist, Volume 24, Issue 1, January 2019, Pages 38–46, https://doi.org/10.1634/theoncologist.2017-0622
Published: 23 May 2018
Advertisement
Advertisement